{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-171086","form_type":"8-K","ticker":"SLDB","cik":"0001707502","company_name":"Solid Biosciences Inc.","filed_at":"2022-06-09T23:59:59+00:00","discovered_at":"2026-05-14T18:04:01.927413+00:00","generated_at":"2026-06-25T03:13:45.150448+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Solid Biosciences stockholders approve reverse stock split and authorized share increase","bullets":["Elected Class I directors Huffines, Nagendran, Shah with ~65.9M votes each.","Ratified PricewaterhouseCoopers as auditor for FY2022: 87.3M for, 226.9K against.","Approved reverse stock split at ratio of 1:5 to 1:15, board to set exact ratio before 2023 annual meeting.","Approved increase in authorized shares to 300M multiplied by 3x the reverse split ratio.","Reverse split and share increase subject to board discretion; may be abandoned."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-171086","json":"https://secwatch.observer/filing/0001193125-22-171086.json","markdown":"https://secwatch.observer/filing/0001193125-22-171086.md","text":"https://secwatch.observer/filing/0001193125-22-171086.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1707502/000119312522171086/0001193125-22-171086-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1707502/000119312522171086/d344917d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T03:13:45.150448+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}